VRSN Stock Cash Flow Statements

VeriSign Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

VeriSign Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31

cash flows from operating activities:
net income	207,400,000	199,300,000	191,500,000	201,300,000	198,800,000	194,100,000	264,700,000	188,500,000	185,700,000	178,700,000	179,500,000	169,500,000	167,300,000	157,500,000	330,082,000	156,622,000	147,772,000	150,354,000	157,314,000	170,979,000	152,479,000	334,116,000	148,325,000	153,913,000	147,534,000	162,527,000	182,195,000	137,680,000	128,351,000	134,263,000	102,837,000	114,899,000	123,100,000	116,412,000	105,552,000	114,427,000	113,210,000	107,456,000	101,530,000	92,457,000	93,011,000	88,238,000	65,472,000	95,189,000	100,176,000	94,423,000	292,149,000	80,898,000	86,890,000	84,513,000	105,641,000	77,910,000	68,472,000	68,009,000	53,814,000	58,916,000	-10,610,000	40,771,000	-40,505,000	785,545,000	36,374,000	52,440,000	93,353,000	54,599,000	35,772,000	65,515,000		-200,034,000	-55,560,000	-18,587,000	-215,542,000	19,004,000	-4,717,000	61,753,000	-29,532,000	15,274,000	373,502,000	19,771,000	271,417,000	44,574,000	41,295,000	49,175,000	114,812,000	40,398,000	21,945,000	9,070,000
adjustments to reconcile net income to net cash from operating activities:
depreciation of property and equipment	8,300,000	8,900,000	8,800,000	9,000,000	9,300,000	9,800,000	10,400,000	10,800,000	11,300,000	11,600,000	11,700,000	11,400,000	11,900,000	11,900,000	12,331,000	12,032,000	12,003,000	11,574,000	11,889,000	11,622,000	11,609,000	11,232,000	12,003,000	11,443,000	11,291,000	11,593,000	11,917,000	12,255,000	12,078,000	12,117,000	12,213,000	12,493,000	12,070,000	13,102,000	14,053,000	14,697,000	14,550,000	14,867,000	14,937,000	14,934,000	15,873,000	15,747,000		15,809,000																			21,746,000	17,205,000	17,807,000	17,309,000		24,370,000	29,269,000	31,815,000	29,961,000	29,014,000	27,388,000	28,176,000		28,347,000
stock-based compensation expense	15,900,000	17,500,000	15,900,000	15,800,000	14,300,000	15,100,000	14,700,000	15,500,000	15,700,000	13,800,000	14,400,000	16,300,000	13,700,000	14,200,000
amortization of discount on investments in debt securities	-1,200,000	-3,600,000	-4,500,000	-5,500,000	-4,100,000	-7,000,000													-287,000	-749,000	-2,092,000	-3,003,000	-4,506,000	-4,592,000	-1,825,000	-3,854,000	-5,513,000	-5,060,000	-3,558,000	-4,128,000
other	300,000	1,100,000	1,500,000	500,000	600,000	1,000,000	18,900,000	-8,300,000	-4,400,000	-2,900,000	-4,600,000	-800,000	900,000	600,000	617,000	1,012,000	3,243,000	1,155,000	6,063,000	368,000	-4,698,000	1,692,000	1,542,000	1,232,000	1,041,000	-147,000	-815,000	591,000	1,092,000	87,000	8,875,000	-4,616,000	-2,890,000	-1,436,000	-843,000	-1,530,000	-635,000	-779,000	-9,757,000	3,319,000	2,141,000	2,701,000	2,516,000	3,668,000	2,798,000	2,371,000	-4,217,000	7,513,000	-678,000	10,742,000	-4,669,000	4,703,000	9,941,000	1,006,000	6,161,000	5,177,000	-502,000	2,129,000	1,039,000	-4,514,000	6,679,000	6,270,000	2,384,000	-4,202,000
changes in operating assets and liabilities:
other assets	-20,100,000	200,000	5,800,000	1,000,000	-15,100,000	-4,100,000	2,200,000	-2,700,000	-2,900,000	1,900,000	12,000,000	-3,600,000	-7,200,000	8,300,000	5,677,000	-1,133,000	-11,844,000	-6,758,000	1,893,000	-961,000	-10,174,000	28,000	8,844,000	-1,869,000	-10,028,000	-226,000		688,000	-6,618,000	-987,000		-3,744,000	-5,886,000	14,196,000																																		1,137,000	7,239,000	-5,289,000	-365,000	1,650,000	851,000	1,138,000	1,418,000	2,976,000			957,000	-2,113,000	15,000	-3,283,000	1,917,000	-2,810,000	402,000	-436,000
other liabilities	-31,400,000	6,600,000	3,000,000	26,900,000	-50,800,000	-8,000,000
deferred revenues	18,300,000	57,200,000	5,200,000	10,300,000	4,000,000	38,600,000	-16,000,000	1,500,000	-300,000	41,800,000	-16,400,000	53,900,000	-100,000	28,300,000	-4,392,000	44,887,000	13,823,000	36,153,000	1,336,000	-2,757,000	7,623,000	22,807,000	-8,372,000	-7,294,000	2,638,000	29,219,000	-5,019,000	-2,452,000	176,000	27,120,000	-7,442,000	-1,456,000	-2,443,000	36,689,000	-5,123,000	-6,876,000	-4,652,000	30,998,000	21,201,000	8,540,000	6,665,000	34,582,000	-2,719,000	2,622,000	4,231,000	30,384,000	-2,160,000	1,612,000	9,590,000	34,212,000	3,937,000	4,896,000	20,459,000	54,719,000	5,628,000	9,091,000	14,906,000	35,908,000	9,276,000	9,675,000	25,297,000	35,983,000	8,871,000	-70,000	6,288,000	25,792,000	2,738,000	30,862,000	21,799,000	40,503,000	28,924,000
net deferred income taxes	5,000,000	4,100,000	4,300,000	-5,900,000	3,400,000	17,800,000	-76,900,000	7,500,000
net cash from operating activities	202,500,000	291,300,000	231,500,000	253,400,000	160,400,000	257,300,000	204,200,000	245,300,000	145,300,000	259,000,000	216,900,000	262,200,000	144,900,000	207,100,000	206,243,000	260,065,000	142,508,000	198,336,000	195,221,000	139,590,000	215,312,000	180,060,000	193,598,000	208,119,000	164,845,000	187,330,000	218,500,000	187,461,000	201,817,000	89,989,000	199,193,000	174,671,000	180,711,000	148,186,000	195,472,000	168,186,000	160,665,000	143,626,000	188,535,000	155,322,000	174,956,000	132,669,000	170,473,000	167,738,000	121,109,000	141,629,000	147,440,000	134,484,000	146,836,000	150,637,000	170,759,000	121,622,000	134,971,000	110,278,000	124,214,000	108,451,000	12,949,000	90,287,000	46,727,000	-81,841,000	149,200,000	101,120,000	173,149,000	100,777,000	82,827,000	38,438,000	122,977,000	115,285,000	169,478,000	74,303,000	206,222,000	109,206,000	111,055,000	43,977,000	143,677,000	92,796,000	144,585,000	93,721,000	171,282,000	125,579,000	140,066,000	73,860,000	134,956,000	84,477,000	98,403,000	47,502,000
capex	-7,800,000	-5,800,000	-9,500,000	-5,600,000	-9,200,000	-3,800,000	-5,000,000	-28,600,000	-6,500,000	-5,700,000	-7,700,000	-6,900,000	-6,200,000	-6,600,000	-13,497,000	-15,266,000	-17,549,000	-6,721,000	-6,462,000	-15,042,000	-10,878,000	-11,013,000	-8,818,000	-11,309,000	-11,056,000	-9,133,000	-7,410,000	-10,928,000	-11,007,000	-7,662,000	-8,890,000	-21,635,000	-9,320,000	-9,654,000	-6,685,000	-6,431,000	-6,376,000	-7,082,000	-11,997,000	-6,768,000	-8,849,000	-13,042,000	-9,269,000	-11,311,000	-7,485,000	-11,262,000	-15,393,000	-12,651,000	-20,435,000	-17,115,000	-13,155,000	-13,626,000	-13,325,000	-12,917,000	-129,216,000	-33,963,000	-13,916,000	-15,565,000	-11,881,000	-25,874,000	-22,874,000	-19,898,000	-50,809,000	-25,252,000	-19,821,000	-20,994,000	0	-19,402,000	-33,681,000	-25,939,000	-57,970,000	-46,756,000	-32,386,000	-15,125,000	-42,567,000	-35,475,000	-76,756,000	-26,813,000	-67,244,000	-27,435,000	-28,766,000	-17,054,000	-35,527,000	-21,622,000	-20,674,000	-14,709,000
free cash flows	194,700,000	285,500,000	222,000,000	247,800,000	151,200,000	253,500,000	199,200,000	216,700,000	138,800,000	253,300,000	209,200,000	255,300,000	138,700,000	200,500,000	192,746,000	244,799,000	124,959,000	191,615,000	188,759,000	124,548,000	204,434,000	169,047,000	184,780,000	196,810,000	153,789,000	178,197,000	211,090,000	176,533,000	190,810,000	82,327,000	190,303,000	153,036,000	171,391,000	138,532,000	188,787,000	161,755,000	154,289,000	136,544,000	176,538,000	148,554,000	166,107,000	119,627,000	161,204,000	156,427,000	113,624,000	130,367,000	132,047,000	121,833,000	126,401,000	133,522,000	157,604,000	107,996,000	121,646,000	97,361,000	-5,002,000	74,488,000	-967,000	74,722,000	34,846,000	-107,715,000	126,326,000	81,222,000	122,340,000	75,525,000	63,006,000	17,444,000	122,977,000	95,883,000	135,797,000	48,364,000	148,252,000	62,450,000	78,669,000	28,852,000	101,110,000	57,321,000	67,829,000	66,908,000	104,038,000	98,144,000	111,300,000	56,806,000	99,429,000	62,855,000	77,729,000	32,793,000
cash flows from investing activities:
proceeds from maturities and sales of marketable securities	38,200,000	358,600,000	185,500,000	282,000,000	69,600,000	658,000,000	528,100,000	29,500,000	159,300,000	562,000,000	246,500,000	417,600,000	361,400,000	696,000,000	408,309,000	763,196,000	689,095,000	793,857,000	501,191,000	809,347,000	189,446,000	805,748,000	724,042,000	57,559,000	526,742,000	939,561,000	950,107,000	447,326,000	702,446,000	1,931,930,000	666,486,000	1,538,727,000	1,307,153,000	1,049,795,000		973,092,000	1,155,797,000	900,810,000		682,400,000	957,968,000	325,399,000		306,398,000	1,400,684,000	718,177,000		689,317,000	858,215,000	706,244,000	840,479,000	385,576,000	3,041,000	5,060,000
purchases of marketable securities	-243,400,000	-35,200,000	-196,700,000	-215,900,000	-310,300,000	-157,800,000	-419,000,000	-213,900,000	-551,100,000	-146,500,000	-429,100,000	-444,100,000	-300,300,000	-164,900,000	-448,965,000	-798,139,000	-661,226,000	-962,340,000	-261,968,000	-925,757,000	-437,173,000	-730,507,000	-308,860,000	-699,920,000	-524,962,000	-496,779,000	-909,254,000	-475,095,000	-960,947,000	-631,456,000	-531,047,000	-2,047,049,000	-1,538,279,000	-813,459,000	-773,314,000	-815,880,000	-1,227,832,000	-874,031,000	-775,464,000	-696,840,000	-1,489,610,000	-257,415,000	-995,573,000	-238,866,000	-1,258,567,000	-784,090,000	-933,354,000	-958,990,000	-793,456,000	-764,268,000	-1,043,664,000	-481,565,000	-1,092,587,000	-5,082,000
purchases of property and equipment	-7,800,000	-5,800,000	-9,500,000	-5,600,000	-9,200,000	-3,800,000	-5,000,000	-28,600,000	-6,500,000	-5,700,000	-7,700,000	-6,900,000	-6,200,000	-6,600,000	-13,497,000	-15,266,000	-17,549,000	-6,721,000	-6,462,000	-15,042,000	-10,878,000	-11,013,000	-8,818,000	-11,309,000	-11,056,000	-9,133,000	-7,410,000	-10,928,000	-11,007,000	-7,662,000	-8,890,000	-21,635,000	-9,320,000	-9,654,000	-6,685,000	-6,431,000	-6,376,000	-7,082,000	-11,997,000	-6,768,000	-8,849,000	-13,042,000	-9,269,000	-11,311,000	-7,485,000	-11,262,000	-15,393,000	-12,651,000	-20,435,000	-17,115,000	-13,155,000	-13,626,000	-13,325,000	-12,917,000	-129,216,000	-33,963,000	-13,916,000	-15,565,000	-11,881,000	-25,874,000	-22,874,000	-19,898,000	-50,809,000	-25,252,000	-19,821,000	-20,994,000		-19,402,000	-33,681,000	-25,939,000	-57,970,000	-46,756,000	-32,386,000	-15,125,000	-42,567,000	-35,475,000	-76,756,000	-26,813,000	-67,244,000	-27,435,000	-28,766,000	-17,054,000	-35,527,000	-21,622,000	-20,674,000	-14,709,000
net cash from investing activities	-213,000,000	317,600,000	-20,700,000	60,500,000	-249,900,000	496,400,000	104,100,000	-213,000,000	-398,300,000	409,800,000	-190,300,000	-33,400,000	54,900,000	524,500,000	-54,153,000	-50,209,000	10,320,000	-175,204,000	233,562,000	-131,452,000	-253,452,000	79,084,000	405,022,000	-655,889,000	-12,629,000	430,691,000	85,683,000	-38,697,000	-269,508,000	1,292,652,000	126,543,000	-529,963,000	-240,430,000	238,774,000	10,363,000	7,746,000	-78,205,000	19,697,000	13,524,000	-21,138,000	-540,440,000	51,155,000	-1,341,000	56,498,000	134,672,000	-77,141,000	306,023,000	-283,049,000	44,529,000	-78,565,000	-216,290,000	-109,733,000	-1,103,391,000	-12,939,000	-129,933,000	108,289,000	318,402,000	-23,516,000	-13,694,000	1,113,976,000	-39,699,000	-457,493,000	153,743,000	21,592,000	230,991,000	78,129,000	265,375,000	-239,681,000	68,743,000	-15,682,000	9,903,000	-17,185,000	24,681,000	194,686,000	-84,604,000	-116,450,000	-263,558,000	-97,784,000	268,442,000	-70,444,000	-56,819,000	-27,248,000	106,284,000	-154,870,000	-185,815,000	-50,462,000
cash flows from financing activities:
repayment of borrowings	0	-500,000,000													0	0																															0	0
proceeds from senior note issuance, net of issuance costs	-600,000	493,900,000														-1,254,000
repurchases of common stock	-166,800,000	-241,700,000	-262,300,000	-303,100,000	-390,300,000	-269,900,000	-225,600,000	-222,400,000	-222,900,000	-230,500,000	-214,100,000	-277,900,000	-351,500,000	-204,600,000	-185,790,000	-175,598,000	-175,785,000	-185,414,000	-173,749,000	-173,879,000	-154,203,000	-275,623,000	-199,098,000	-198,953,000	-180,230,000	-204,302,000	-178,349,000	-178,206,000	-128,856,000	-152,741,000	-146,883,000	-148,531,000	-152,711,000	-173,048,000	-160,557,000	-177,699,000	-151,875,000	-172,360,000	-150,594,000	-156,690,000	-157,555,000	-178,330,000	-209,863,000	-226,864,000	-301,120,000	-145,556,000	-225,550,000	-331,919,000	-335,256,000	-142,892,000	-94,289,000	-78,666,000	-77,576,000	-75,149,000	-1,294,000	-238,132,000	-103,243,000	-207,428,000	-15,515,000	-152,291,000	-228,190,000	-53,753,000	-208,889,000	-29,045,000	-21,276,000	-1,361,000		-128,303,000	-1,870,000	-1,146,510,000
payment of dividends
payment of excise tax on repurchase of common stock
proceeds from employee stock purchase plan	0	7,900,000	0	4,000,000	0	8,300,000	0	4,300,000	0	8,000,000	0	4,100,000	0	8,200,000	0	4,303,000	0	8,101,000	0	4,281,000	0	8,296,000	0	4,899,000	0	8,253,000	0	5,025,000	0	7,811,000	0	4,918,000	0	7,997,000
net cash from financing activities	-251,100,000	-239,900,000	-270,500,000	-299,100,000	-390,300,000	-261,600,000	-226,300,000	-218,100,000	-222,900,000	-222,500,000	-214,100,000	-273,800,000	-351,500,000	-196,400,000	-185,812,000	-172,549,000	-183,456,000	-177,313,000	-173,749,000	-169,598,000	-154,203,000	-267,327,000	-199,970,000	-194,054,000	-180,230,000	-196,049,000	-178,349,000	-173,181,000	-1,378,865,000	-144,930,000	-146,883,000	399,572,000	-152,711,000	-165,051,000	-151,065,000	-169,255,000	-145,185,000	-158,258,000	-151,550,000	-142,960,000	-153,531,000	330,263,000	-210,594,000	-226,761,000	-285,509,000	-136,888,000	-232,319,000	-312,635,000	309,972,000	-122,351,000	-93,888,000	-58,314,000	-65,547,000	-60,003,000	117,859,000	-229,187,000	-553,607,000	-187,263,000	-533,940,000	30,890,000	-213,615,000	-28,609,000	-279,688,000	-11,042,000	49,671,000	43,065,000		-93,163,000	-95,970,000	-960,594,000	98,276,000	289,306,000	82,000	-198,993,000	-522,000	37,647,000	114,162,000	-40,552,000	-267,991,000	-194,008,000	-21,378,000	13,864,000	-56,066,000	-22,244,000	8,707,000	15,131,000
effect of exchange rate changes on cash, cash equivalents, and restricted cash	400,000	-300,000		400,000	100,000	-400,000		-400,000	0	-200,000		-700,000	-600,000	-100,000		-236,000	-162,000	-202,000		459,000	351,000	-1,316,000		-451,000	-12,000	255,000		-395,000	-757,000	167,000
net increase in cash, cash equivalents, and restricted cash	-261,200,000	368,700,000		15,200,000	-479,700,000	491,700,000		-186,200,000	-475,900,000	446,100,000		-45,700,000	-152,300,000	535,100,000							-191,992,000	-9,499,000			-28,026,000	422,227,000		-24,812,000	-1,447,313,000	1,237,878,000
cash, cash equivalents, and restricted cash at beginning of period	0	212,100,000	0	0	0	245,500,000	0	0	0	379,000,000	0	0	0	228,800,000	0	0	0	410,601,000	0	0	0	517,601,000	0	0	0	366,753,000	0	0	0	475,139,000
cash, cash equivalents, and restricted cash at end of period	-261,200,000	580,800,000	-60,600,000	15,200,000	-479,700,000	737,200,000	82,500,000	-186,200,000	-475,900,000	825,100,000	-186,900,000	-45,700,000	-152,300,000	763,900,000	-33,683,000	37,071,000	-30,790,000	256,218,000	255,492,000	-161,001,000	-191,992,000	508,102,000	398,922,000	-642,275,000	-28,026,000	788,980,000	125,861,000	-24,812,000	-1,447,313,000	1,713,017,000
supplemental cash flow disclosures:
cash paid for interest	16,100,000	26,200,000	23,300,000	13,100,000	23,300,000	13,100,000	23,300,000	13,100,000	23,300,000	13,100,000	23,200,000	13,200,000	23,300,000	13,100,000	23,733,000	13,127,000	35,562,000	13,156,000	30,494,000	13,152,000	30,557,000	13,151,000	30,609,000	13,366,000	30,645,000	13,063,000	30,772,000	13,213,000	30,645,000	43,326,000	30,612,000	27,825,000	30,608,000	28,189,000	30,614,000	27,294,000	30,608,000	27,028,000																														20,313,000	296,000	20,146,000
cash paid for income taxes, net of refunds received	129,400,000	20,000,000	43,400,000	48,500,000	122,500,000	16,100,000	60,900,000	46,400,000	114,100,000	18,300,000	52,100,000	46,300,000	111,100,000	2,200,000	46,149,000	33,209,000	81,707,000	17,286,000	27,425,000	78,786,000	10,558,000	15,914,000	14,777,000	12,983,000	48,029,000	14,185,000	473,000	-1,164,000	12,638,000	72,959,000	5,577,000	-945,000	5,801,000	17,861,000	-171,000	480,000	283,000	13,711,000	26,434,000	-1,053,000	1,372,000	12,970,000	264,000	473,000	26,813,000	7,651,000	9,078,000	-476,000	16,802,000	729,000	-539,000	-1,218,000	8,007,000	13,186,000																	3,455,000	8,073,000	3,248,000	6,524,000		8,665,000	4,747,000	6,955,000		4,291,000	5,114,000	9,735,000
payment of excise tax on repurchases of common stock
other financing activities																																																			0	0	0	189,000	178,000				-4,000	0	-390,000	-346,000
effect of exchange rate changes on cash, cash equivalents and restricted cash
net increase in cash, cash equivalents and restricted cash
proceeds from borrowings, net of issuance costs																																							0	0	-1,587,000	493,824,000
accounts payable and accrued liabilities								32,500,000	-60,300,000	11,600,000	26,700,000	15,100,000	-27,000,000	-14,900,000	21,024,000	31,258,000	-29,174,000	-7,613,000	8,139,000	-31,708,000	53,205,000	-27,409,000	7,086,000	32,241,000	-7,742,000	-31,609,000	27,348,000	-8,586,000	15,379,000	-36,271,000	25,007,000	21,042,000	29,323,000	-59,889,000	48,529,000	20,368,000	2,884,000	-31,537,000	6,355,000	19,436,000	24,038,000	-28,816,000	47,959,000	-1,671,000	33,710,000	-34,579,000	-27,894,000	17,095,000	25,541,000	4,549,000	-3,711,000	7,433,000	28,228,000	-44,872,000	25,500,000	15,398,000	-5,922,000	-16,814,000	26,345,000	11,474,000	30,867,000	-33,734,000	28,462,000	8,664,000	62,012,000	-42,467,000		-10,289,000	-22,485,000	-81,620,000	81,422,000	-51,900,000	21,416,000	-127,657,000	-20,691,000	12,088,000	31,346,000	-38,127,000	28,044,000	-11,115,000	67,100,000	16,286,000	54,859,000	27,306,000	5,151,000	-42,405,000
net deferred income taxes and other long-term tax liabilities										2,500,000	-6,400,000	400,000	-14,600,000	1,200,000	-171,516,000	959,000	-6,932,000	497,000	3,139,000	-19,882,000	-4,627,000	-170,844,000	17,104,000	10,425,000	8,781,000	7,365,000	43,462,000	36,506,000	33,264,000	-59,108,000	45,746,000	25,496,000	21,114,000	20,775,000	31,217,000	20,358,000	17,562,000	18,477,000	27,125,000	17,958,000	18,591,000	18,654,000
changes in operating assets and liabilities
proceeds from sale of business
proceeds (payments) from sale of business																						14,856,000
stock-based compensation																14,428,000	13,617,000	12,974,000	12,137,000	12,678,000	11,987,000	11,441,000	12,389,000	12,620,000	13,155,000	12,462,000	11,098,000	15,130,000	13,298,000	12,978,000	12,864,000	14,105,000	13,375,000	12,563,000	14,299,000	12,854,000	11,132,000	11,759,000	11,724,000	12,222,000	12,001,000	10,128,000	9,696,000	14,916,000	9,372,000	9,993,000	9,643,000	10,577,000	8,835,000	7,594,000	6,971,000	9,807,000	8,454,000	8,130,000	7,165,000	7,093,000	14,064,000	14,950,000	9,977,000	16,891,000	13,225,000	12,085,000	11,761,000	11,309,000	14,168,000	13,928,000	14,698,000	29,272,000										15,146,000
proceeds received related to sale of business
net decrease in cash, cash equivalents, and restricted cash																37,071,000	-30,790,000	-154,383,000
gain on sale of business																															0	186,000
other investing activities																								-2,219,000	-3,353,000	-2,958,000	0	0	0	-160,000	-6,000	-6,000	16,000	12,092,000	2,162,000	-35,000			-275,000	70,000	51,000	-3,787,000	101,000	277,000	40,000	34,000	-23,000	-725,000	205,000	-3,426,000	50,000	-118,000			50,000	2,000	0	-1,181,000	-100,000	-915,000			-292,000	166,000	-3,672,000	206,000
repayment of principal on subordinated convertible debentures																											0	0
proceeds received (payments made) related to sale of business																				0
(payments) proceeds from sale of business
proceeds from senior notes, net of issuance costs																																															0	-434,000
loss on debt extinguishment																											0	0
payment of contingent interest																															0	-7,513,000	0	-7,719,000	0	-6,841,000	0	-6,544,000	0	-5,534,000	0	-5,225,000
amortization of debt discount and issuance costs																											709,000	709,000	1,801,000	3,918,000	3,851,000	3,779,000	3,555,000	3,493,000	3,440,000	3,381,000	3,323,000	3,267,000
prepaid expenses and other assets																																			-8,834,000	2,384,000	8,906,000	6,524,000	-4,695,000	-4,402,000	10,453,000	-3,084,000				7,925,000	-4,373,000	2,670,000	-4,201,000	3,210,000	-26,431,000						-16,761,000	3,975,000	-21,179,000	-25,323,000	17,708,000	9,689,000	-40,147,000	2,945,000	19,164,000	-29,380,000
deposits to acquire intangible assets																																			0
unrealized gain on contingent interest derivative on subordinated convertible debentures																																							5,072,000	4,747,000	-2,708,000	7,019,000
effect of exchange rate changes on cash and cash equivalents																															176,000	116,000	264,000	738,000	-610,000	142,000	-334,000	301,000	279,000	-639,000	422,000	184,000	-879,000	-887,000	36,000	230,000	488,000	490,000	-1,656,000	-1,837,000	-300,000	1,259,000	-3,452,000	2,355,000	-1,579,000	-4,930,000	1,595,000	1,690,000	340,000	10,891,000	363,000	-2,154,000	-2,344,000	12,627,000	2,477,000	-6,314,000	11,491,000	67,000	-4,259,000	8,276,000	1,008,000	3,697,000	-1,775,000	791,000	-1,014,000	-129,000	862,000	287,000
net increase in cash and cash equivalents																															179,029,000	44,396,000	-212,166,000	222,647,000				5,366,000				514,271,000							499,681,000	-52,116,000				39,691,000	110,561,000				-500,567,000	1,197,272,000	-227,107,000	-387,136,000	44,860,000	123,954,000	365,966,000	153,318,000		-217,492,000	137,992,000	-893,697,000	315,409,000	385,024,000	134,043,000	40,461,000			-3,949,000	-44,328,000			60,202,000	58,736,000	191,388,000	-94,825,000	-80,412,000	12,897,000
cash and cash equivalents at beginning of period																															0	0	0	231,945,000	0	0	0	228,659,000	0	0	0	191,608,000	0	0	0	339,223,000	0	0	0	130,736,000	0	0	0	1,313,349,000		0	0	1,559,628,000	0	0	0	1,477,166,000		0	0	789,068,000		0	0	1,376,722,000		0	0	501,784,000		0	1,834,000	476,826,000		0	0	330,641,000		0	0	393,787,000
cash and cash equivalents at end of period																															179,029,000	44,396,000	-212,166,000	454,592,000	54,160,000	6,819,000	-63,059,000	234,025,000	50,788,000	-9,415,000	-518,593,000	705,879,000	-42,341,000	-3,412,000	-29,692,000	267,053,000	221,632,000	-460,710,000	499,681,000	78,620,000	-139,719,000	-45,166,000	-1,037,419,000	1,353,040,000		-17,377,000	-220,661,000	1,440,826,000	-500,567,000	1,197,272,000	-227,107,000	1,090,030,000		123,954,000	365,966,000	942,386,000		-217,492,000	137,992,000	483,025,000		385,024,000	134,043,000	542,245,000		13,864,000	-2,115,000	432,498,000		-139,635,000	60,202,000	389,377,000		-94,825,000	-80,412,000	406,684,000
excess tax benefit associated with stock-based compensation																																			-9,492,000	-2,858,000	-6,690,000	-6,018,000	956,000	-8,054,000	-5,373,000	-5,993,000	2,512,000	6,743,000			10,775,000	-12,453,000	-5,834,000	-11,808,000	2,329,000	-9,127,000	-8,071,000	-3,567,000	-11,569,000	-997,000	2,761,000	-3,615,000	35,268,000	-154,741,000	-4,356,000	-8,097,000	74,703,000	-6,054,000
unrealized (gain) loss on contingent interest derivative on subordinated convertible debentures																																			9,000	-1,440,000	94,000	-1,065,000					1,704,000	6,562,000	-5,246,000	-5,269,000
accounts receivable																																			2,665,000	-738,000	981,000	-3,779,000	1,980,000	-301,000	264,000	-1,282,000	2,477,000	-2,317,000	1,573,000	-1,806,000	1,025,000	-1,262,000	17,000	-2,280,000	-275,000	1,389,000	821,000	1,392,000	-213,000	-392,000	1,339,000	-985,000	1,993,000	1,070,000	5,505,000	4,579,000	11,279,000	5,717,000	338,000	8,464,000	23,500,000	-638,000	32,211,000	-1,025,000	8,930,000	-2,425,000	-64,984,000	-45,859,000	15,679,000	-26,682,000	25,834,000	17,525,000	-771,000	14,179,000	-17,234,000	-59,993,000	-15,028,000	-36,701,000	-9,670,000	-4,423,000
proceeds from maturities and sales of marketable securities and investments																																																							2,503,000	173,917,000	358,348,000	11,238,000	74,137,000	43,635,000	100,136,000	95,909,000
proceeds from issuance of common stock from option exercises and employee stock purchase plans																																			0	5,586,000	0	8,084,000	0	5,676,000	238,000	8,776,000	1,781,000	6,846,000	302,000	8,668,000	4,006,000	7,265,000	663,000	8,733,000	2,730,000	11,225,000	3,958,000	11,390,000	8,473,000	9,065,000	15,895,000	16,550,000	36,068,000	28,440,000	10,609,000	17,393,000					1,958,000	28,064,000	46,210,000	46,195,000
net decrease in cash and cash equivalents																																				6,819,000				-9,415,000						-72,170,000						-45,166,000					-220,661,000	-118,802,000
(gain) loss on investments
cash paid for interest, net of capitalized interest																																							30,795,000	25,839,000	17,345,000	25,494,000	17,321,000	20,260,000	17,298,000	20,209,000	18,493,000	19,940,000	102,000	20,393,000	447,000	20,353,000	440,000	20,036,000	146,000	19,965,000	100,020,000	20,062,000	109,242,000	19,817,000	0	19,811,000	0	19,735,000	0	19,521,000
depreciation of property and equipment and amortization of other intangible assets																																														16,008,000	15,240,000	14,889,000	15,408,000	15,118,000	15,167,000	13,379,000	13,532,000	12,741,000		13,813,000	13,674,000	13,968,000		13,573,000	17,901,000	21,905,000
gain on sale of investments
deferred income taxes																																												21,282,000	-44,792,000	22,179,000	-141,688,000	12,945,000	11,268,000	4,787,000																		5,975,000	-15,310,000	-4,045,000	-27,484,000	27,911,000	-16,592,000	5,123,000	71,943,000	-3,349,000	-292,490,000	-3,298,000	-1,280,000	-1,495,000	-5,077,000	-2,038,000				-537,000
income taxes receivable and other assets																																												4,935,000
payment of dividends to stockholders																																																							0	0
proceeds received from borrowings
net gain on sale of discontinued operations, net of tax
proceeds received from divestiture of businesses, net of cash contributed and transaction costs																																																											-2,724,000
payable to purchasers of divested businesses
deferred tax assets and other assets																																																					-6,865,000	12,720,000	23,477,000
depreciation and amortization
loss on sale and impairment of other long-lived assets
changes in operating assets and liabilities, excluding the effects of acquisitions and divestitures:
purchases of marketable securities and investments																																																							-3,270,000	-31,667,000	-26,030,000	-18,008,000	-73,126,000	-52,317,000	-113,188,000	-549,087,000
proceeds from sale of property and equipment																																																																			0	0	47,557,000	1,286,000
cash and cash equivalents at beginning of year
cash and cash equivalents at end of year
(payable) receivable to/from purchasers of divested businesses
proceeds received from divestiture of businesses, net of cash contributed																																																													0	15,583,000			233,128,000	2,372,000	14,320,000	0
cash and cash equivalents included in assets held for sale
net (gain) loss on sale of discontinued operations, net of tax																																																											10,237,000
amortization of other intangible assets																																																															2,805,000	3,112,000	3,061,000	3,221,000	2,905,000	5,306,000	5,495,000	11,957,000	25,371,000	29,237,000	29,669,000	31,787,000	31,958,000	30,977,000	31,832,000	28,000,000		26,235,000	24,821,000	22,840,000				15,110,000
impairment of goodwill
cash received from trust, previously restricted																																																																			0
reclassification of cash equivalents to other current assets
investment in unconsolidated entities
(gain) loss on sale of discontinued operations, net of tax and estimated losses (reversals) on assets held for sale
accrued restructuring costs																																																															715,000	-1,748,000	-4,092,000	-17,001,000	-2,146,000
proceeds from maturities and sales of investments																																																															11,578,000	0	23,885,000	94,016,000	98,195,000	1,340,000	0	100,000	61,858,000	-103,279,000	56,216,000	191,912,000			570,088,000	86,054,000	82,709,000	53,045,000	126,192,000	51,899,000	875,551,000	48,461,000	45,639,000	97,607,000
investments in unconsolidated entities																																																																							0
repayment of short-term debt																																																																						-60,000,000	0
proceeds from issuance of convertible debentures, net of issuance costs																																																																							-353,000
receivable from purchasers of divested businesses
gain on divestiture of businesses, net of tax																																																																8,695,000			46,138,000	-1,224,000
estimated (reversals) losses on assets held for sale
loss on sale and impairment of long-lived assets
reclassification of cash equivalents to short-term investments
proceeds received from divestiture of businesses, net of cash provided
proceeds from issuance of common stock from option exercises and employee stock purchase plan																																																																11,961,000	3,812,000	17,133,000					86,982,000				-1,128,000	13,244,000	9,498,000	29,926,000	23,810,000	20,746,000	21,884,000	14,014,000	22,896,000	13,620,000	8,455,000	17,455,000
proceeds from credit facility																																																																				0	0	200,000,000
repayment of short-term debt related to credit facility																																																																				0
dividend paid to noncontrolling interest in subsidiary																																																																-12,000
dividend payable to noncontrolling interest in subsidiary																																																																-12,000	-101,000	807,000
estimated losses (reversals) on assets held for sale
loss on disposal of property and equipment																																																																															0	0	59,000	127,000
unrealized gain on contingent interest derivative on convertible debentures																																																																		-1,174,000			-246,000	-1,838,000
estimated (gains) losses on assets held for sale																																																																		-4,477,000
gain on receipt of acquisition termination fee																																																																		-3,279,000
benefit from doubtful accounts																																																																		329,000	797,000	-47,000	591,000	575,000	966,000	604,000	436,000	-1,156,000	-2,741,000	924,000	1,302,000	-650,000	-208,000	-1,240,000	1,914,000	575,000	-1,505,000	1,865,000	28,000	301,000
loss on disposal of property and equipment and other																																																																		1,658,000
income from unconsolidated entities, net of tax
purchases of investments																																																																		-750,000					0	135,571,000	0	-135,882,000	-5,000,000	-506,000	-497,710,000	-38,353,000	-19,902,000	-52,902,000	-125,270,000	-78,795,000	-813,878,000	-174,239,000	-33,871,000	-61,215,000
proceeds received from acquisition termination fee																																																																		3,279,000
excess tax benefit associated with stock options																																																																		27,293,000	48,641,000
gain on sale of investments in unconsolidated entities, net of tax
unrealized gain on joint venture call options																																																																							-3,178,000	-3,992,000
unrealized (gain) loss on contingent interest derivative on convertible debentures
depreciation of property and equipment and other
impairment of long-lived assets and other charges
acquired in-process research and development																																																																											0	1,200,000	4,600,000	10,900,000	1,570,000	1,800,000
net (gain) loss on sale and other-than-temporary impairment of investments
minority interest, net of tax																																																																				815,000	989,000	906,000	1,299,000	2,054,000	-82,000	569,000
reclassification of cash equivalents to prepaid expenses and other assets
cash paid in business combinations, net of cash acquired																																																																												-121,034,000	-256,329,000	-166,458,000
proceeds from sale of investments in unconsolidated entities
proceeds received on long term note receivable
proceeds from contingent purchase price adjustment																																																																			0
change in net assets of subsidiary																																																																												85,000	741,000	-494,000
proceeds from credit facility, net of issuance costs
repayment of long-term liabilities																																																																													-856,000	-824,000
preferred stock received as consideration for divestiture of business
receivable from divestiture of business
impairments and other charges
loss on sale of property and equipment																																																																				116,000
net income on sale and other-than-temporary impairment of investments
loss (earnings) from unconsolidated entities, net of tax																																																																				2,509,000	-1,551,000	2,141,000
prepaid expenses and other current assets																																																																				6,714,000	-10,264,000	20,594,000	469,000	2,392,000	54,915,000	75,746,000	13,545,000	-2,564,000	-88,565,000	-2,930,000	9,267,000	18,502,000	-40,505,000	-13,543,000	6,372,000	6,527,000	509,000	-3,812,000
proceeds from repayment of promissory note by unconsolidated entities
change in net assets of minority interest																																																																				0	72,000	62,000
dividend paid to minority interest holders in subsidiary
amounts payable for purchases of property and equipment
impairment of goodwill, other intangible assets and assets held for sale
restructuring and other charges
net gain on sale and impairment of investments																																																																												-14,000	28,000	-21,274,000
proceeds received from contingent purchase price adjustment
dividend paid to minority interest																																																																					-382,000	-341,000
cash and cash equivalents of jamba service at end of period
cash and cash equivalents of continuing operations at end of period																																																																					137,992,000	483,025,000		404,795,000	133,493,000	523,024,000
net gain on divestiture of businesses																																																																						-816,000
impairment of assets held for sale																																																																						25,511,000
stock-based compensation and other																																																																						22,550,000	23,870,000	19,333,000	25,322,000	16,725,000	17,241,000	16,219,000
restructuring, impairments and other charges																																																																						26,465,000				27,012,000
impairment of equity investment																																																																						327,000
gain on sale of property and equipment																																																																						-728,000
net gain on sale of investments																																																																						-382,000	2,721,000	-49,000	-56,000	-829,000
proceeds received on divestiture of majority ownership interest in jamba, net of cash contributed
net proceeds from sale of discontinued operations																																																																						14,160,000
gain on divestiture of businesses
gain on divestiture of discontinued operations
realized and unrealized loss on embedded derivative																																																																							2,712,000
amortization of debt issuance costs																																																																							285,000
restructuring, impairments and other charges (reversals)																																																																							65,913,000	2,006,000
income tax associated with stock options
changes in operating assets and liabilities, excluding effects of acquisitions:
cash paid for business combinations, net of cash acquired																																																																																			0	0
proceeds received on divestiture of businesses, net of cash contributed
proceeds received on divestiture of discontinued operations
change in net assets of subsidiary and other																																																																							768,000	-525,000	82,000	7,000
repurchase of common stock																																																																							-1,728,000				0	0	-60,000,000	-75,000,000	-291,509,000	-214,644,000			-78,322,000
proceeds from draw-down of credit facility, net of issuance costs
cash and cash equivalents of discontinued operations at end of year
cash and cash equivalents of continuing operations at end of year
note receivable from divested business
gain on divestiture of majority stake in jamba																																																																								0	0	-74,999,000
gain on sale of discontinued operations
earnings from unconsolidated entities, net of tax																																																																								-216,000	-1,748,000	-448,000
proceeds received on divestiture of majority stake in jamba, net of cash contributed																																																																								0	0	152,643,000
proceeds from sale of discontinued operations
net proceeds received on long-term note receivable
proceeds from drawdown of credit facility, net of issuance costs
cash and cash equivalents of discontinued operations at end of period																																																																									-550,000	-19,221,000
deferred revenue																																																																									28,664,000	48,034,000	23,057,000	19,741,000	19,439,000	41,601,000	-1,077,000	13,916,000	23,259,000	36,698,000	7,708,000	13,752,000	19,854,000	28,003,000
proceeds from drawdown of credit facility																																																																												125,000,000
repayment of short-term-debt
debt issuance costs																																																																											0	0
cash flows from discontinued operations:
repayment of debt																																																																										-199,000,000									-666,000	-975,000	-147,000	-2,703,000
depreciation and amortization of property and equipment																																																																														24,444,000	24,379,000	22,348,000	21,778,000	20,804,000	20,459,000	22,205,000	21,470,000	21,507,000
restructuring, impairment and other charges (reversals)
net (gain) loss on sale and impairment of investments																																																																															-3,045,000	-8,169,000	0	-96,000
gain on sale of verisign japan stock
minority interest
tax benefit (expense) associated with stock options
proceeds from sale of verisign japan stock
proceeds from draw-down of credit facility
repayment of credit facility
repayment of long term liabilities
cash and cash equivalents of at beginning of year
cash and cash equivalents included in discontinued operations
cash and cash equivalents of continuing operations at the end of the year
restructuring, impairment, and other reversals
minority interest in net income of subsidiary																																																																														647,000		1,221,000	1,048,000	1,128,000				293,000
tax benefit associated with stock options																																																																															41,240,000	3,201,000	13,246,000	3,091,000	3,876,000	-24,473,000	17,604,000	7,741,000
proceeds from maturities/sales of investments
net proceeds received on long-term note receivable and investment																																																																														47,786,000
repayment of debt and long-term liabilities
cash and cash equivalents of discontinued operations																																																																												-1,039,000	-2,710,000	-1,248,000
restructuring, impairment and other reversals
impairment of other intangible assets																																																																														1,950,000
non-cash restructuring and other charges																																																																														16,000	22,512,000	0	40,000	106,000	1,992,000	4,526,000	731,000	12,705,000
dividend income from investment																																																																																		-2,180,000
excess tax benefits from stock-based compensation																																																																														5,840,000
amortization and impairment of other intangible assets and goodwill																																																																																			23,317,000	22,790,000
minority interest in net income of consolidated subsidiary																																																																																			741,000	748,000
amortization of unearned compensation																																																																															1,968,000	1,622,000	1,842,000	880,000	734,000	935,000	826,000	641,000
payments received on long term note receivable
merger related costs																																																																															255,000	-1,704,000	-8,201,000	-15,000	-96,000	-4,660,000	-1,918,000	-746,000
proceeds from sale of consolidated subsidiary stock																																																																																			26,000
net cash from discontinued operations
noncash investing and financing activities:
issuance of restricted stock and restricted stock units
issuance of common stock for business combinations
unrealized gain on investments
cash paid for income taxes
net cash paid in business combinations																																																																																-38,731,000						-70,963,000
payment received on long-term note receivable and dividend																																																																																-604,000	-2,787,000	20,000,000
proceeds from sale of stock from consolidated subsidiary																																																																																440,000	-235,000	400,000				379,000
payment of long-term liabilities																																																																																-550,000	-550,000	-550,000
effect of exchange rate changes																																																																																-762,000	-1,667,000	-1,740,000	6,214,000	-2,188,000	-1,707,000	726,000
reciprocal transactions for purchases of property and equipment
net income on sale and impairment of investments																																																																																			-66,000	4,599,000	359,000	3,308,000
unrealized gain on investments, net of tax
proceeds from sale of stock into consolidated subsidiary
proceeds from sale of stock in consolidated subsidiary

We provide you with 20 years of cash flow statements for VeriSign stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of VeriSign stock. Explore the full financial landscape of VeriSign stock with our expertly curated income statements.

The information provided in this report about VeriSign stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.